1. Hunter, TM, Boytsov, NN, Zhang, X, Schroeder, K, Michaud, K, Araujo, AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int. 2017;37(9):1551-1557. doi:10.1007/s00296-017-3726-1.
Google Scholar | Crossref | Medline2. Krock, E, Jurczak, A, Svensson, CI. Pain pathogenesis in rheumatoid arthritis-what have we learned from animal models? Pain. 2018;159(suppl 1):S98-S109. doi:10.1097/j.pain.0000000000001333.
Google Scholar | Crossref | Medline3. Walsh, DA, McWilliams, DF. Mechanisms, impact and management of pain in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(10):581-592. doi:10.1038/nrrheum.2014.64.
Google Scholar | Crossref | Medline4. Matcham, F, Rayner, L, Steer, S, Hotopf, M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology. 2013;52(12):2136-2148. doi:10.1093/rheumatology/ket169.
Google Scholar | Crossref | Medline5. Englbrecht, M, Alten, R, Aringer, M, et al. New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis—implications from the prospective multicenter VADERA II study. PLoS One. 2019;14(5). doi:10.1371/journal.pone.0217412.
Google Scholar | Crossref | Medline6. Matcham, F, Galloway, J, Hotopf, M, et al. The impact of targeted RA pharmacologic treatment on mental health. Arthritis Rheumatol. 2018;70:1377-1391. doi:10.1002/art.40565.
Google Scholar | Crossref | Medline7. Rathbun, AM, Harrold, LR, Reed, GW. Temporal effect of depressive symptoms on the longitudinal evolution of RA disease activity. Arthritis Care Res. 2015;67(6):765-775. doi:10.1002/acr.22515.
Google Scholar | Crossref8. Husted, JA, Tom, BD, Farewell, VT, Gladman, DD. Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis. Arthritis Care Res. 2012;64:758-765. doi:10.1002/acr.21602.
Google Scholar | Crossref | Medline9. Schieir, O, Thombs, BD, Hudson, M, et al. Symptoms of depression predict the trajectory of pain among patients with early inflammatory arthritis: a path analysis approach to assessing change. J Rheumatol. 2009;36(2):231-239. doi:10.3899/jrheum.080147.
Google Scholar | Crossref | Medline | ISI10. ten Klooster, PM, Veehof, MM, Taal, E, van Riel, PL, van, de, Laar, MA. Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment. Ann Rheum Dis. 2007;66(11):1485-1490. doi:10.1136/ard.2007.069765.
Google Scholar | Crossref | Medline11. Zhao, SS, Duffield, SJ, Goodson, NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019;33(3):101423. doi:10.1016/j.berh.2019.06.005.
Google Scholar | Crossref | Medline12. Kaeley, N, Ahmad, S, Pathania, M, Kakkar, R. Prevalence and patterns of peripheral neuropathy in patients of rheumatoid arthritis. J Family Med Prim Care. 2019;8(1):22-26. doi:10.4103/jfmpc.jfmpc_260_18.
Google Scholar | Crossref | Medline13. Ahmed, S, Magan, T, Vargas, M, Harrison, A, Sofat, N. Use of the painDETECT tool in rheumatoid arthritis suggests neuropathic and sensitization components in pain reporting. J Pain Res. 2014;7:579-588. doi:10.2147/JPR.S69011.
Google Scholar | Crossref | Medline14. Richards, BL. Antidepressants for pain management in RA. Cochrane Database of Systematic Reviews. 2011;11:CD008920. doi:10.1002/14651858.CD008920.pub2.
Google Scholar | Crossref15. Fiest, KM, Hitchon, CA, Bernstein, CN, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with rheumatoid arthritis. J Clin Rheumatol. 2017;23(8):425-434. doi:10.1097/RHU.0000000000000489.
Google Scholar | Crossref | Medline16. Grace, EM, Bellamy, N, Kassam, Y, Buchanan, WW. Controlled, double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis. Curr Med Res Opin. 1985;9(6):426-429. doi:10.1185/03007998509109614.
Google Scholar | Crossref | Medline17. Bird, H, Broggini, M. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. J Rheumatol. 2000;27(12):2791-2797.
Google Scholar | Medline18. Frank, RG, Kashani, JH, Parker, JC, et al. Antidepressant analgesia in RA. J Rheumatol. 1988;15(11):1632-1638.
Google Scholar | Medline19. Macfarlane, JG, Jalali, S, Grace, EM. Trimipramine in rheumatoid arthritis: a randomized double-blind trial in relieving pain and joint tenderness. Curr Med Res Opin. 1986;10(2):89-93. doi:10.1185/03007998609110424.
Google Scholar | Crossref | Medline20. Fowler, PD, MacNeill, A, Spencer, D, Robinson, ET, Dick, WC. Imipramine, rheumatoid arthritis and rheumatoid factor. Curr Med Res Opin. 1977;5(3):241-246. doi:10.1185/03007997709110172.
Google Scholar | Crossref | Medline21. Lee, YC, Massarotti, E, Edwards, RR, et al. Effect of milnacipran on pain in patients with RA with widespread pain: a randomized blinded crossover trial. J Rheumatol. 2016;43(1):38-45. doi:10.3899/jrheum.150550.
Google Scholar | Crossref | Medline22. Parker, JC, Smarr, KL, Slaughter, JR, et al. Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach. Arthritis Rheum. 2003;49(6):766-777. doi:10.1002/art.11459.
Google Scholar | Crossref | Medline23. Ash, G, Dickens, CM, Creed, FH, Jayson, MI, Tomenson, B. The effects of dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology. 1999;38(10):959-967. doi:10.1093/rheumatology/38.10.959.
Google Scholar | Crossref | Medline24. Sarzi Puttini, P, Cazzola, M, Boccassini, L, et al. A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depression. J Int Med Res. 1988;16(5):331-337. doi:10.1177/030006058801600502.
Google Scholar | SAGE Journals25. Yoshii, I, Chijiwa, T. Effectiveness of duloxetine for remnant pain relief in patients with rheumatoid arthritis despite remission. Drugs Ther Perspect. 2020;36(7):288-292. https://doi.org/10.1007/s40267-020-00739-5.
Google Scholar | Crossref26. Practice guideline for the treatment of patients with major depressive disorder (revision) . American Psychiatric Association. Am J Psychiatry. 2000;157(4 suppl):1-45.
Google Scholar27. Macfarlane, GJ, Kronisch, C, Dean, LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-328. doi:10.1136/annrheumdis-2016-209724.
Google Scholar | Crossref | Medline28. Bates, D, Schultheis, BC, Hanes, MC, et al. A comprehensive algorithm for management of neuropathic pain. Pain Med. 2019;20(suppl 1):S2-S12. doi:10.1093/pm/pnz075.
Google Scholar | Crossref | Medline29. Medicines.org.au . https://apps.medicines.org.au/files/afpdothe.pdf. Updated 2019. Accessed October 6, 2021.
Google Scholar30. Highlights of prescribing information . http://www.allergan.com/Assets/PDF/Savella_pi. Updated 2017. Accessed April 29, 2021.
Google Scholar31. Wolfe, F, Rasker, JJ. The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol. 2006;33(11):2291-2299.
Google Scholar | Medline32. Highlights of prescribing information . http://labeling.pfizer.com/ShowLabeling.aspx?id=517. Updated 2021. Accessed October 4, 2021.
Google Scholar33. Santarsieri, D, Schwartz, TL. Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context. 2015;4. doi:10.7573/dic.212290.
Google Scholar | Crossref | Medline34. Moraczewski, J, Aedma, KK. Tricyclic Antidepressants. StatPearls, FL: StatPearls; 2021 Jan. https://www.ncbi.nlm.nih.gov/books/NBK557791/. Accessed December 13, 2021.
Google Scholar